BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2001
View Archived Issues
Idec reports status of select products
Read More
Biogen makes considerable pipeline progress during Q1 2001
Read More
CPMP, FDA panel recommend approval of Ketek for community-acquired RTIs
Read More
Menjugate receives expedited approval in Canada
Read More
Medarex and Northwest Biotherapeutics enter cancer therapy alliance
Read More
Exelixis to acquire Artemis
Read More
Photogen products advance in clinical trials
Read More
Inhibitors of STAT3 activation identified using new high-throughput assay
Read More
Potential small-molecule cancer therapeutic designed at Agouron to be selective for VEGF RTK
Read More
MMP-1-sparing MMP inhibitor demonstrates activity against lung, prostate and breast cancers
Read More
Company Profile: Newron Pharmaceuticals
Read More
Health Canada seeks more information to support Hemolink NDS
Read More
Titanium-based antiviral compound presented at Antiviral Research conference
Read More
Preclinical and clinical profile of Neotrofin reviewed by NeoTherapeutics at AD/PD meeting
Read More
Incara's catalytic antioxidants show promise in preclinical studies in the therapy of cancer
Read More
Idun licenses SMAC gene from UT Southwestern Medical Center
Read More
Titan and Novartis expand Zomaril agreement to include Japan
Read More
Beta-sheet-forming peptide designed as novel antiangiogenic agent
Read More
Icos initiates phase III trial of Pafase for treatment of severe sepsis
Read More
Ovarian cancer vaccines prepared at Corixa
Read More
Novel calpain protease discovered by Millennium team
Read More
New adenosine A2A antagonists and use described by Roche
Read More
Aventis discloses series of HSL inhibitors
Read More
Potential atypical antipsychotic agents in the Egis pipeline
Read More
New series of selective ERalpha ligands designed at Akzo Nobel
Read More
Indena focuses on modulators of MDR
Read More
Forbes Medi-Tech halts CardioRex development; steps up development of second-generation compound
Read More